Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome (original) (raw)

References

1. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150. doi:10.1200/JCO.2005.05.2308
   Article PubMed Google Scholar
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917. doi:10.1002/ijc.25516
   Article CAS PubMed Google Scholar
3. Winawer SJ, Zauber AG (2002) The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 12(1):1–9, v
   Article PubMed Google Scholar
4. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474(7351):327–336. doi:10.1038/nature10213
   Article CAS PubMed Central PubMed Google Scholar
5. Vipperla K, O’Keefe SJ (2012) The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract 27(5):624–635. doi:10.1177/0884533612452012
   Article PubMed Google Scholar
6. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottière HM, Raes J, Ehrlich D, Doré J (2013) A metagenomic insight into our gut’s microbiome. Gut 62(1):146–158. doi:10.1136/gutjnl-2011-301805
   Article PubMed Google Scholar
7. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15(8):1183–1189. doi:10.1002/ibd.20903
   Article CAS PubMed Google Scholar
8. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133(1):24–33. doi:10.1053/j.gastro.2007.04.005
   Article CAS PubMed Google Scholar
9. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100(2):373–382. doi:10.1111/j.1572-0241.2005.40312.x
   Article CAS PubMed Google Scholar
10. Nyangale EP, Mottram DS, Gibson GR (2012) Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11(12):5573–5585. doi:10.1021/pr300637d
    CAS PubMed Google Scholar
11. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, Tjalsma H (2011) Towards the human colorectal cancer microbiome. PLoS One 6(5):e20447. doi:10.1371/journal.pone.0020447
    Article CAS PubMed Central PubMed Google Scholar
12. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123. doi:10.1126/science.1224820
    Article CAS PubMed Central PubMed Google Scholar
13. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L (2012) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6(2):320–329. doi:10.1038/ismej.2011.109
    Article CAS PubMed Central PubMed Google Scholar
14. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R (1997) High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 25(4):605–607
    Article CAS PubMed Google Scholar
15. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H (1998) Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115(2):281–286
    Article CAS PubMed Google Scholar
16. Konstantinov SR, Kuipers EJ, Peppelenbosch MP (2013) Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol 10(12):741–745. doi:10.1038/nrgastro.2013.178
    Article CAS PubMed Google Scholar
17. Scanlan PD, Shanahan F, Clune Y, Collins JK, O’Sullivan GC, O’Riordan M, Holmes E, Wang Y, Marchesi JR (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10(3):789–798. doi:10.1111/j.1462-2920.2007.01503.x
    Article CAS PubMed Google Scholar
18. Jobin C (2013) Colorectal cancer: looking for answers in the microbiota. Cancer Discov 3(4):384–387. doi:10.1158/2159-8290.CD-13-0042
    Article CAS PubMed Central PubMed Google Scholar
19. Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC (2013) Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therap Adv Gastroenterol 6(3):215–229. doi:10.1177/1756283X12473674
    Article PubMed Central PubMed Google Scholar
20. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22(2):299–306. doi:10.1101/gr.126516.111
    Article CAS PubMed Central PubMed Google Scholar
21. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22(2):292–298. doi:10.1101/gr.126573.111
    Article CAS PubMed Central PubMed Google Scholar
22. Citron DM (2002) Update on the taxonomy and clinical aspects of the genus Fusobacterium. Clin Infect Dis 35(Suppl 1):S22–S27. doi:10.1086/341916
    Article PubMed Google Scholar
23. Moore WE, Moore LV (1994) The bacteria of periodontal diseases. Periodontol 2000 5:66–77
    Article CAS PubMed Google Scholar
24. Swidsinski A, Dörffel Y, Loening-Baucke V, Tertychnyy A, Biche-Ool S, Stonogin S, Guo Y, Sun ND (2012) Mucosal invasion by fusobacteria is a common feature of acute appendicitis in Germany, Russia, and China. Saudi J Gastroenterol 18(1):55–58. doi:10.4103/1319-3767.91734
    Article PubMed Central PubMed Google Scholar
25. Roberts GL (2000) Fusobacterial infections: an underestimated threat. Br J Biomed Sci 57(2):156–162
    CAS PubMed Google Scholar
26. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, DeVinney R, Lynch T, Allen-Vercoe E (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978. doi:10.1002/ibd.21606
    Article PubMed Google Scholar
27. Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, Genco RJ (2000) Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68(6):3140–3146
    Article CAS PubMed Central PubMed Google Scholar
28. Dharmani P, Strauss J, Ambrose C, Allen-Vercoe E, Chadee K (2011) Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect Immun 79(7):2597–2607. doi:10.1128/IAI.05118-11
    Article CAS PubMed Central PubMed Google Scholar
29. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO (2013) Fusobacterium is associated with colorectal adenomas. PLoS One 8(1):e53653. doi:10.1371/journal.pone.0053653
    Article CAS PubMed Central PubMed Google Scholar
30. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207–215
    Article CAS PubMed Google Scholar
31. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195–206. doi:10.1016/j.chom.2013.07.012
    Article CAS PubMed Google Scholar
32. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O’Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA (2012) IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491(7423):259–263. doi:10.1038/nature11535
    Article CAS PubMed Central PubMed Google Scholar
33. Sharara AI, Abou Hamdan T, Malli A, El-Halabi MM, Hashash JG, Ghaith OA, Kanj SS (2013) Association of Streptococcus bovis endocarditis and advanced colorectal neoplasia: a case–control study. J Dig Dis 14(7):382–387. doi:10.1111/1751-2980.12059
    Article PubMed Google Scholar
34. Gentili V, Gianesini S, Balboni PG, Menegatti E, Rotola A, Zuolo M, Caselli E, Zamboni P, Di Luca D (2012) Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™. Eur J Clin Microbiol Infect Dis 31(7):1523–1529. doi:10.1007/s10096-011-1473-x
    Article CAS PubMed Central PubMed Google Scholar
35. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J; MetaHIT Consortium, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M’Rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174–180. doi:10.1038/nature09944
    Article CAS PubMed Central PubMed Google Scholar
36. Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11(7):622–629
    PubMed Google Scholar
37. Hill MJ, Morson BC, Bussey HJ (1978) Aetiology of adenoma—carcinoma sequence in large bowel. Lancet 1(8058):245–247
    Article CAS PubMed Google Scholar
38. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, Chen Y, Yang F, Lu N, Wang Z, Luan C, Liu Y, Wang B, Xiang C, Wang Y, Zhao F, Gao GF, Wang S, Li L, Zhang H, Zhu B (2013) Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 66(2):462–470. doi:10.1007/s00248-013-0245-9
    Article CAS PubMed Google Scholar
39. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68(7):3401–3407
    Article CAS PubMed Central PubMed Google Scholar
40. Peyret-Lacombe A, Brunel G, Watts M, Charveron M, Duplan H (2009) TLR2 sensing of F. nucleatum and S. sanguinis distinctly triggered gingival innate response. Cytokine 46(2):201–210. doi:10.1016/j.cyto.2009.01.006
    Article CAS PubMed Google Scholar

Download references